US Stock MarketDetailed Quotes

UTHR United Therapeutics

Watchlist
  • 304.420
  • -13.450-4.23%
Close Mar 11 16:00 ET
  • 305.000
  • +0.580+0.19%
Post 17:42 ET
13.67BMarket Cap12.35P/E (TTM)

United Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
23.63%2.88B
19.72%735.9M
22.89%748.9M
19.85%714.9M
33.70%677.7M
20.20%2.33B
25.07%614.7M
18.10%609.4M
27.76%596.5M
9.74%506.9M
Operating revenue
23.63%2.88B
19.72%735.9M
22.89%748.9M
19.85%714.9M
33.70%677.7M
20.20%2.33B
25.07%614.7M
18.10%609.4M
27.76%596.5M
9.74%506.9M
Cost of revenue
20.27%309.7M
6.90%75.9M
18.54%83.1M
21.37%77.8M
39.39%72.9M
69.85%257.5M
20.75%71M
88.44%70.1M
115.82%64.1M
101.93%52.3M
Gross profit
24.04%2.57B
21.39%660M
23.46%665.8M
19.67%637.1M
33.04%604.8M
15.99%2.07B
25.65%543.7M
12.64%539.3M
21.77%532.4M
4.27%454.6M
Operating expense
26.49%1.12B
4.48%296.3M
21.34%257.6M
44.84%317.2M
46.00%248.5M
9.95%885.1M
10.31%283.6M
29.06%212.3M
-6.97%219M
15.00%170.2M
Selling and administrative expenses
33.85%638.6M
22.92%162.5M
20.77%154.1M
36.62%177.6M
65.41%144.4M
-1.04%477.1M
-19.00%132.2M
29.67%127.6M
-8.13%130M
10.51%87.3M
-Selling and marketing expense
17.73%96.3M
12.03%27M
0.00%20.7M
26.37%25.4M
37.28%23.2M
15.54%81.8M
4.78%24.1M
20.35%20.7M
24.84%20.1M
16.55%16.9M
-General and administrative expense
37.19%542.3M
25.35%135.5M
24.79%133.4M
38.49%152.2M
72.16%121.2M
-3.89%395.3M
-22.90%108.1M
31.65%106.9M
-12.36%109.9M
9.15%70.4M
Research and development costs
17.89%481M
-11.62%133.8M
22.20%103.5M
56.85%139.6M
25.57%104.1M
26.35%408M
61.24%151.4M
28.14%84.7M
-5.22%89M
20.14%82.9M
Operating profit
22.21%1.45B
39.83%363.7M
24.83%408.2M
2.07%319.9M
25.28%356.3M
20.95%1.18B
48.12%260.1M
4.04%327M
55.30%313.4M
-1.25%284.4M
Net non-operating interest income expense
51.06%156.2M
15.32%41.4M
33.67%39.7M
54.46%34.6M
162.99%40.5M
707.81%103.4M
322.35%35.9M
624.39%29.7M
3,633.33%22.4M
3,950.00%15.4M
Non-operating interest income
22.37%199.1M
-3.33%49.3M
9.93%49.8M
24.19%46.2M
84.25%53.8M
259.96%162.7M
145.19%51M
240.60%45.3M
447.06%37.2M
579.07%29.2M
Non-operating interest expense
-27.66%42.9M
-47.68%7.9M
-35.26%10.1M
-21.62%11.6M
-3.62%13.3M
83.02%59.3M
22.76%15.1M
69.57%15.6M
138.71%14.8M
193.62%13.8M
Other net income (expense)
-366.43%-65.3M
-1,333.33%-8.6M
-1,110.20%-59.3M
233.33%800K
122.78%1.8M
66.59%-14M
88.68%-600K
16.95%-4.9M
98.84%-600K
-137.44%-7.9M
Special income (charges)
---71.1M
---6M
---65.1M
----
----
--0
--0
--0
----
----
-Less:Other special charges
--71.1M
--6M
--65.1M
----
----
----
----
----
----
----
-Write off
--0
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
141.43%5.8M
-333.33%-2.6M
218.37%5.8M
233.33%800K
122.78%1.8M
65.17%-14M
88.68%-600K
16.95%-4.9M
98.84%-600K
-134.65%-7.9M
Income before tax
20.77%1.54B
34.22%396.5M
10.46%388.6M
6.00%355.3M
36.55%398.6M
34.05%1.27B
65.21%295.4M
12.58%351.8M
122.58%335.2M
-5.44%291.9M
Income tax
18.79%343.9M
21.58%95.2M
-5.58%79.5M
1.58%77.2M
80.39%92M
29.65%289.5M
67.67%78.3M
15.03%84.2M
119.65%76M
-25.87%51M
Net income
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
Net income continuous Operations
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
Minority interest income
Net income attributable to the parent company
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
27.27%306.6M
35.40%984.8M
64.35%217.1M
11.83%267.6M
123.45%259.2M
0.42%240.9M
Basic earnings per share
25.67%26.44
45.89%6.74
21.37%6.93
13.20%6.26
25.38%6.52
31.66%21.04
60.42%4.62
8.56%5.71
116.02%5.53
-2.07%5.2
Diluted earnings per share
24.38%24.64
41.97%6.19
18.77%6.39
11.64%5.85
26.95%6.17
32.07%19.81
63.30%4.36
9.57%5.38
117.43%5.24
-3.38%4.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 23.63%2.88B19.72%735.9M22.89%748.9M19.85%714.9M33.70%677.7M20.20%2.33B25.07%614.7M18.10%609.4M27.76%596.5M9.74%506.9M
Operating revenue 23.63%2.88B19.72%735.9M22.89%748.9M19.85%714.9M33.70%677.7M20.20%2.33B25.07%614.7M18.10%609.4M27.76%596.5M9.74%506.9M
Cost of revenue 20.27%309.7M6.90%75.9M18.54%83.1M21.37%77.8M39.39%72.9M69.85%257.5M20.75%71M88.44%70.1M115.82%64.1M101.93%52.3M
Gross profit 24.04%2.57B21.39%660M23.46%665.8M19.67%637.1M33.04%604.8M15.99%2.07B25.65%543.7M12.64%539.3M21.77%532.4M4.27%454.6M
Operating expense 26.49%1.12B4.48%296.3M21.34%257.6M44.84%317.2M46.00%248.5M9.95%885.1M10.31%283.6M29.06%212.3M-6.97%219M15.00%170.2M
Selling and administrative expenses 33.85%638.6M22.92%162.5M20.77%154.1M36.62%177.6M65.41%144.4M-1.04%477.1M-19.00%132.2M29.67%127.6M-8.13%130M10.51%87.3M
-Selling and marketing expense 17.73%96.3M12.03%27M0.00%20.7M26.37%25.4M37.28%23.2M15.54%81.8M4.78%24.1M20.35%20.7M24.84%20.1M16.55%16.9M
-General and administrative expense 37.19%542.3M25.35%135.5M24.79%133.4M38.49%152.2M72.16%121.2M-3.89%395.3M-22.90%108.1M31.65%106.9M-12.36%109.9M9.15%70.4M
Research and development costs 17.89%481M-11.62%133.8M22.20%103.5M56.85%139.6M25.57%104.1M26.35%408M61.24%151.4M28.14%84.7M-5.22%89M20.14%82.9M
Operating profit 22.21%1.45B39.83%363.7M24.83%408.2M2.07%319.9M25.28%356.3M20.95%1.18B48.12%260.1M4.04%327M55.30%313.4M-1.25%284.4M
Net non-operating interest income expense 51.06%156.2M15.32%41.4M33.67%39.7M54.46%34.6M162.99%40.5M707.81%103.4M322.35%35.9M624.39%29.7M3,633.33%22.4M3,950.00%15.4M
Non-operating interest income 22.37%199.1M-3.33%49.3M9.93%49.8M24.19%46.2M84.25%53.8M259.96%162.7M145.19%51M240.60%45.3M447.06%37.2M579.07%29.2M
Non-operating interest expense -27.66%42.9M-47.68%7.9M-35.26%10.1M-21.62%11.6M-3.62%13.3M83.02%59.3M22.76%15.1M69.57%15.6M138.71%14.8M193.62%13.8M
Other net income (expense) -366.43%-65.3M-1,333.33%-8.6M-1,110.20%-59.3M233.33%800K122.78%1.8M66.59%-14M88.68%-600K16.95%-4.9M98.84%-600K-137.44%-7.9M
Special income (charges) ---71.1M---6M---65.1M----------0--0--0--------
-Less:Other special charges --71.1M--6M--65.1M----------------------------
-Write off --0------------------0----------------
Other non- operating income (expenses) 141.43%5.8M-333.33%-2.6M218.37%5.8M233.33%800K122.78%1.8M65.17%-14M88.68%-600K16.95%-4.9M98.84%-600K-134.65%-7.9M
Income before tax 20.77%1.54B34.22%396.5M10.46%388.6M6.00%355.3M36.55%398.6M34.05%1.27B65.21%295.4M12.58%351.8M122.58%335.2M-5.44%291.9M
Income tax 18.79%343.9M21.58%95.2M-5.58%79.5M1.58%77.2M80.39%92M29.65%289.5M67.67%78.3M15.03%84.2M119.65%76M-25.87%51M
Net income 21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M
Net income continuous Operations 21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M
Minority interest income
Net income attributable to the parent company 21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M27.27%306.6M35.40%984.8M64.35%217.1M11.83%267.6M123.45%259.2M0.42%240.9M
Basic earnings per share 25.67%26.4445.89%6.7421.37%6.9313.20%6.2625.38%6.5231.66%21.0460.42%4.628.56%5.71116.02%5.53-2.07%5.2
Diluted earnings per share 24.38%24.6441.97%6.1918.77%6.3911.64%5.8526.95%6.1732.07%19.8163.30%4.369.57%5.38117.43%5.24-3.38%4.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Strategy
MSTR
260.590
Coinbase
COIN
191.690
Tesla
TSLA
230.580
4
Vale SA
VALE
9.400
5
Salesforce
CRM
277.050
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.